Diabetes Mental Health Obesity Impact on Lifestyle Impact on Daily Life Arthritis Public Awareness Hypertension Public Health Diabetes Management Vision Impairment Back Pain Fibroids Youth Health ADHD Anemia Support Systems Congenital Disorders Diet-Related Diseases Patient Advocacy Allergies Post-Surgery Complications Incontinence Solutions Impact on Family Long Covid Autoimmune Diseases Quality of Life Prediabetes ADHD and Treatment Patient Rights Invisible Illnesses Living with Illness Pollen Allergy Digestive Disorders Pain Awareness Thrombosis Heart Disease Social Support Osteoporosis Pain Management Sleep Apnoea Menopause Patient Care Stroke Risk Factors Mobility Impairments Impact on Families Heart Health Elderly Care Cardiovascular Health Access to Healthcare Kidney Stones Metabolic Disorders Genetic Disorders Migraine Patient Support Impact on Employment Economic Impact Under-treatment Sickle Cell Disease Workplace Challenges Covid-19 Hypertension and Diabetes Diabetes Awareness Women’s Health Lipödem Temporomandibular Disorder Lifestyle Changes Impact of COVID-19 Impact on Individuals Awareness Uterine Fibroids Gastrointestinal Disorders Syndrome of Turner Transplant Awareness
The funding positions the company for regulatory filings once its SOPHIA2 pivotal study concludes.
